This was a descriptive non-interventional study in HIV-1-infected patients treated with DRV/r conducted in the clinical setting, with a single-arm prospective design. The primary objective was to collect data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in the marketing authorization. Efficacy (measured as viral load [VL] <50 copies/mL and CD4+ cell count) was evaluated for DRV/r in combination with other antiretroviral (ARV) agents in routine clinical practice in Italy.
Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice / A. Antinori, M. Galli, N. Gianotti, C. Mussini, T. Quirino, K. Sterrantino, D. Mancusi, R. Termini. - In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. - ISSN 1758-2652. - 17:4 suppl. 3(2014 Nov 02), pp. 19786.1-19786.2. ((Intervento presentato al convegno International Congress of Drug Therapy in HIV Infection tenutosi a Glasgow nel 2014.
|Titolo:||Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice|
GALLI, MASSIMO (Secondo)
|Settore Scientifico Disciplinare:||Settore MED/17 - Malattie Infettive|
|Data di pubblicazione:||2-nov-2014|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.7448/IAS.17.4.19786|
|Appare nelle tipologie:||01 - Articolo su periodico|